Bristol-Myers Squibb’s transformation can be summarized in the phrase “to build a diversified biopharma company”
In Conversation
Roland Berger’s Patrick Biecheler discusses the French healthcare system, their role in offering specialized consultancy services to the pharmaceutical sector, and the digitalization of the healthcare…
For over 25 years now, [Mapi] has been a pioneer, looking beyond simply safety and efficacy evaluations and developing technical expertise in gathering and assessing patient perspectives.
Lyon has a unique capacity to interact and discuss for the benefit of the community; regardless of politics.
Our edge is the design of tailor-made solutions that fit the needs and constraints of large companies, and provides synergies and mutualization for medium or smaller…
This long historical maturation has turned Lyon into one of the most important places for life sciences.
Pharmaceutical manufacturers are increasingly active in health system reform and policy makers are increasingly framing the drug development process. It is therefore natural to treat them…
In my opinion, the trend of CMO pharma manufacturing has only just begun
Collaboration is in the core DNA of our company
Eric Ducournau, CEO of Pierre Fabre Dermo-Cosmétique (PFDC), discusses the company’s revolutionary lines of dermatologically tested skincare products and their niche adapted internationalization strategy that is…
Bernard Fraisse of Fareva, France’s leading CMO, discusses growth, international expansion, loyalty to France, dedication to clients, and commitment to providing high quality products.
